GNTA (Genenta Science SPA) Notes Receivable: $0.00 Mil (As of Dec. 2025)


GNTA Genenta Science SPA GNTA
31 GF Score
Price $1.53
! 4 Warning Signs
View Full Analysis

What is Genenta Science SPA Notes Receivable?

Genenta Science SPA GNTA -5.26% 31 Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates GNTA with a GF Score™ of 31/100. The stock has 4 warning signs investors should review.

Genenta Science SPA's Notes Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

Genenta Science SPA Notes Receivable Related Terms

Genenta Science SPA Notes Receivable Historical Data

* Premium members only.

The historical data trend for Genenta Science SPA's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genenta Science SPA Notes Receivable Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GNTA
31GF Score
Genenta Science SPA GNTA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genenta Science SPA Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Genenta Science SPA (GNTA) has a Notes Receivable of $0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genenta Science SPA and its competitors.
Is Genenta Science SPA's Notes Receivable too high?
Genenta Science SPA's current Notes Receivable is $0.00 Mil. Overall, Genenta Science SPA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's Notes Receivable compare to VRTX and REGN?
Genenta Science SPA's Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Genenta Science SPA and its competitors. Genenta Science SPA's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (GNTA) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Genenta Science SPA's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Genenta Science SPA (GNTA), the current Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genenta Science SPA Business Description

Other Exchanges K5F:Germany
Address Via dell’Annunciata No. 31, Milan, ITA, 20121
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
31GF Score

Get the complete analysis for GNTA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.53
Price